PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAD3. A total of 11 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $12,225,021 | -61.5% | 11,901,000 | -57.3% | 0.00% | -57.1% |
Q1 2023 | $31,737,623 | -57.4% | 27,901,000 | -63.2% | 0.01% | -58.8% |
Q4 2022 | $74,474,061 | -16.4% | 75,901,000 | -0.8% | 0.02% | -15.0% |
Q3 2022 | $89,082,000 | -2.0% | 76,490,000 | -11.6% | 0.02% | -13.0% |
Q2 2022 | $90,901,000 | – | 86,490,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STEELHEAD PARTNERS LLC | 25,000,000 | $26,265,000 | 2.25% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 32,000,000 | $33,439,000 | 0.69% |
AQR Arbitrage LLC | 28,460,000 | $29,840,000 | 0.67% |
WOLVERINE ASSET MANAGEMENT LLC | 23,359,000 | $24,559,000 | 0.25% |
FRANKLIN RESOURCES INC | 63,000,000 | $66,056,000 | 0.03% |
Citadel Advisors | 86,490,000 | $90,901,000 | 0.02% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 600,000 | $626,000 | 0.01% |
LINDEN ADVISORS LP | 500,000 | $522,000 | 0.01% |
BlackRock Inc. | 2,925,000 | $3,052,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |